Former pharmaceutical executive at Novopharm Ltd. and President of Wampole Canada Inc. with over 15 years industry experience. Aubrey is a Canadian businessman, philanthropist as well as a Tony-Award® winning producer (MEMPHIS) who is also the principal of the Dancap Family Investment Office www.dancap.ca. Aubrey received an honorary Doctorate of Laws Degree (honoris causa) from Assumption University in 2008 and from Western University in 2019. He also received a Professional Achievement Award in 2015 from Western University. He is a Governor at Tel Aviv University, sits on the board of Avivagen. Aubrey received the Order of Canada in 2019.

Pharmaceutical industry veteran and senior manager with Novopharm Ltd. and Teva Pharmaceuticals with over 35 years experience. Peter has extensive experience in R&D program management, Decommissioning and Construction of manufacturing facilities and laboratories, Integration of companies, Technology Transfer, ERP selection and implementation. He was the Vice President responsible for the Integration of Novopharm Ltd. with Teva Pharmaceuticals. Peter then became Vice President of Business Process Improvement, responsible for the standardization of all business processes across North America for Teva Pharmaceuticals.

Experienced executive at Novopharm Ltd. and Teva Pharmaceuticals Canada with over 35 years of progressive experience in the Pharmaceutical Industry. He has demonstrated expertise in all aspects of Pharmaceutical Analytical Research and Development and Quality Control Operations including but not limited to Analytical Method and Specifications Development and Validation, releasing of commercial Raw Materials and Finished Product batches, maintaining and trending Compliant Stability programs for North America, carrying out “Out of Specifications/Out of Trend” investigations and Analytical Methodology and Technology Transfers. Over his career, Tamas has developed a strong understanding and very close working relationships with Pharmaceutical Development, Regulatory Affairs (including Chemistry Manufacturing and Controls), Biopharmaceutics (PK/BA/BE) and QA Departments. Tamas has also served as an expert witness for Health Canada.

Finance professional with over 20 years experience, including 15 years in healthcare industry management roles. Completed multiple acquisitions including two public company deals worth in excess of US $1.5B. His past experience includes 2 years as President of the Motion Intelligence division of Quadrant Biosciences, 9 years with Zimmer Biomet including roles as the Global Head of Finance for Zimmer Biomet’s Spine, Dental, and CMF & Thoracic divisions, Senior Director of Finance, Operations and Logistics for Canada and Director of Finance for Canada and Latin America.

20-year veteran of the pharmaceutical industry managing IT teams and leading ERP selection and implementation at Novopharm Ltd. and Teva Pharmaceuticals. Norman has an in-depth knowledge of IT for pharmaceutical manufacturers and distributors. He has led successful regulatory body computer system audits and reviews by both the FDA and Health Canada and is well versed in well versed in FDA 21CFR Part 11 software compliance. He has developed complete ICT environments and infrastructures and developed and implemented full-scale Business Continuity Plans (BCP).

Over 30 years of progressive experience in pharmaceutical quality and compliance operations with Novopharm Ltd., Watson Laboratories (US), Contract Pharmaceutical Laboratories (CPL), Teva Pharmaceuticals and most recently with Apotex Inc. Her high level experience includes Quality systems & operations, Quality Assurance & Compliance, Laboratory expertise, R&D QA functions, Contract development & manufacturing organization (CDMO) management and Agency Inspection.

Ildiko is an accomplished pharmaceutical executive with 30+ years of progressive experience and a strong portfolio of achievements. She has successfully led teams in different areas of pharmaceutical operations, including but not limited to pharmaceutical quality systems, scientific and technical affairs, analytical R&D, and quality control.

She has proven expertise in development and commercialization of both prescription and non-prescription pharmaceutical dosage forms and in understanding related regulatory requirements. She has supported over 70 regulatory submissions (chemistry and manufacturing controls) to different regulatory bodies in her past, resulting in drug approval and commercialization. She has maintained site compliance, led regulatory audits and just recently successfully guided her team to achieve EU GMP compliance for medicinal cannabis manufacturing, packaging and testing.

Her previously held roles include pharmaceutical quality, regulatory, compliance, general management at ARA - Avanti Rx Analytics Inc., Contract Pharmaceuticals Limited, Dalton Pharma Services, Taro Pharmaceuticals Inc., and Novopharm Ltd.

Former President & CEO of Apotex Inc. with 55 years experience in the pharmaceutical industry including generic and branded. Jack spent 10 years in the pharmaceutical Industry as a detail sales representative for a Branded pharmaceutical company before moving over to Director of Government sales for ICN Canada in Montreal. He then joined Apotex Inc. as VP Sales & Marketing progressing to various roles including Chief Executive Officer, Chief Operating officer, President and Vice Chairman.

More than 20 years experience, including international experience in pharma, medical device, biotech and financial services for companies such as Apotex Inc., AstraZeneca, and CIBC. She has been on the Board of Directors of Pele Mountain Resources and worked in Special Initiatives, Risk Management, office of the CRO at CIBC. Her diverse experience includes Product Strategy and Licensing and Emerging Brands for AstraZeneca, launching innovative neuromodulation solutions for Medtronic, and censing specialty pharma for Paladin.

Senior executive with over 20 years experience in the OTC pharmaceutical field with broad ranging contract manufacturing oversight with most of the world’s top-20 research-based pharmaceutical companies. Nancy has been Director of New Business Development for Boehringer Ingelheim (Canada) Ltd. eventually becoming VP of the Consumer Health Division, and responsible for a vitamin and supplement manufacturing facility in Vancouver, B.C. She was VP of North American Business Management for Patheon Inc. responsible for customer relationships in Canada, the U.S. and Puerto Rico, maximizing product life cycle, reducing competitive threats, identifying line extensions, and making strategic manufacturing decisions.

Over 25 years experience as COO and CFO for the Dancap Family Investment Office, overseeing the operational and financial functions of the family investment office. Elias is a Chartered Professional Accountant who, along with Aubrey, has responsibility for all personnel and all aspects of management of the Dancap Investment Portfolios. This includes both direct and fund private-equity commitments, active and passively managed public equity products, real estate holdings, private debt investments and uniquely structured investments.

Rindy is a Pharmaceutical professional with over 25 years of experience, having prior responsibilities for manufacturing, packaging, process improvement, facilities and project management. Prior to joining EmpowerPharm she was the Site Director at Pharmetics in Burlington. Before Pharmetics she was a Senior Operations Manager with Patheon Inc. Rindy’s past experience brings to EmpowerPharm a thorough knowledge across organizational departments and a solid team attitude allowing for effective guidance of multi-functional teams towards results. She brings a customer-centric focus ensuring quality services to both internal and external stakeholders which is key in her role as Site Director for EmpowerPharm. Rindy is a certified Professional Logistician (P.Log) with the Logistics Institute of Canada.

Dr. Fields has 20 years of experience within the pharmaceutical industry, where she headed the global clinical program at Apotex, overseeing scientific affairs, clinical and bioanalytical operations, as well as data management and clinical project management. Dr. Fields was also responsible for the development of clinical/regulatory strategies of the product pipeline. In an earlier role, Dr. Fields was responsible for providing scientific and regulatory guidance on all aspects of study design, statistical analysis, and reporting of bioequivalence and clinical equivalence studies of various dosage forms.

David obtained his BA from McGill University and his joint JD/MBA degrees from Queen’s University. He was called to the New York State Bar after graduation and began his career at Scotiabank with roles in risk management and corporate banking. After leaving the corporate world, David joined a startup in the entertainment technology space as their CFO where he was instrumental in securing a series A investment and expanding into the US market. He is also a founding member of Lay-Up, a charity that has sent over 2500 underprivileged children to leadership basketball camps across Toronto. As a member of the Governance Professionals of Canada, David works with our board of directors to implement best practices for all matters relating to corporate governance.

Peter is a pharmaceutical professional with 30 plus years of proven, progressive oral solid dose experience in Validation, Engineering, Manufacturing, Packaging, Warehousing and Distribution. A highly motivated leader with a proven track record for building, developing and retaining high performance teams within Brand, Generic and Contract Manufacturing Organizations. He has demonstrated success in applying effective problem solving and decision making skills to streamline inefficient processes and implement continuous improvement solutions. Peter is a Licensed Chemical Engineer since 1991 with the Association of Professional Engineers of Ontario.

Giridhar Cheekati (Giri) is an industrial entrepreneur with 27 years of experience in Pharmaceutical & Natural Health Products industries with vast expertise in the areas of Pharmaceutics Research & Development, Commercial manufacturing, Validation, Product life cycle management, Quality Assurance & Compliance. In his past endeavors he was instrumental in integration of companies and technology transfer of novel branded formulations. Giri comes to Empower family with work experience in world renowned companies such as Cipla Ltd., Dr. Reddy’s Laboratories, Merck KGa&A, Mylan and Tilray.